Derek Lowe is a medicinal chemist working on preclinical drug discovery in the pharmaceutical industry. Lowe has published a blog about this field, "In the Pipeline", since 2002 [1] and is a columnist for the Royal Society of Chemistry's Chemistry World . [2]
Lowe (born in Harrisburg, Arkansas) got his BA from Hendrix College and his PhD in organic chemistry from Duke University on synthesis of natural products, before researching for a year in Germany on a Humboldt Fellowship. [3] [4]
Lowe was one of the first people to blog from inside the pharmaceutical industry, with the approval of his supervisor and the company legal department, [5] and one of the first science bloggers. [6] By 2006, his blog had between 3,000 and 4,000 visitors per day during the workweek; he covered business matters, trends and issues in medicinal chemistry, and legal matters like patent law and regulation. [7] At that time he was working at a pharmaceutical company doing hit to lead medicinal chemistry work. [7] As of 2010 [update] his blog received between 15,000 and 20,000 page views on a typical weekday. [8] His response to a 2013 article in BuzzFeed that propagated chemophobia was widely cited. [9] [10] [11]
He serves on the editorial board of ACS Medicinal Chemistry Letters and on the advisory board of Chemical & Engineering News . [12]
As of 2018 [update] he was working at Novartis; formerly he had worked for 10 years at Vertex, 9 years at Bayer, and 8 years at Schering-Plough. [4] [13] [14]
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
